Ceridian HCM (NYSE:CDAY – Get Rating) had its price objective increased by Deutsche Bank Aktiengesellschaft from $80.00 to $82.00 in a research report released on Monday morning, The Fly reports.
Other equities research analysts have also recently issued reports about the stock. Barclays dropped their price target on shares of Ceridian HCM from $66.00 to $64.00 and set an equal weight rating on the stock in a research report on Tuesday, January 10th. Cowen boosted their price objective on Ceridian HCM from $70.00 to $77.00 and gave the stock an outperform rating in a report on Monday, November 14th. JPMorgan Chase & Co. cut their price objective on Ceridian HCM from $75.00 to $70.00 and set a neutral rating on the stock in a report on Thursday, November 3rd. Citigroup cut their price objective on Ceridian HCM from $73.00 to $68.00 in a report on Friday, October 21st. Finally, Moffett Nathanson initiated coverage on Ceridian HCM in a report on Monday, January 9th. They set a market perform rating and a $68.00 price objective on the stock. One analyst has rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, Ceridian HCM currently has a consensus rating of Moderate Buy and a consensus price target of $71.07.
Ceridian HCM Price Performance
Shares of Ceridian HCM stock opened at $72.79 on Monday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.59. The company’s 50-day moving average price is $65.45 and its two-hundred day moving average price is $61.47. Ceridian HCM has a 52 week low of $43.23 and a 52 week high of $81.07. The stock has a market cap of $11.06 billion, a PE ratio of -142.73 and a beta of 1.45.
Insider Buying and Selling at Ceridian HCM
In other Ceridian HCM news, CEO Leagh Erin Turner sold 6,500 shares of Ceridian HCM stock in a transaction dated Wednesday, December 7th. The stock was sold at an average price of $62.74, for a total transaction of $407,810.00. Following the transaction, the chief executive officer now owns 176,643 shares of the company’s stock, valued at approximately $11,082,581.82. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 3.90% of the company’s stock.
Institutional Investors Weigh In On Ceridian HCM
Several large investors have recently made changes to their positions in CDAY. Lazard Asset Management LLC bought a new stake in shares of Ceridian HCM in the 3rd quarter valued at approximately $25,000. Quadrant Capital Group LLC grew its stake in shares of Ceridian HCM by 114.8% in the 2nd quarter. Quadrant Capital Group LLC now owns 844 shares of the company’s stock valued at $40,000 after buying an additional 451 shares in the last quarter. Advisors Asset Management Inc. bought a new stake in shares of Ceridian HCM in the 1st quarter valued at approximately $41,000. Allworth Financial LP grew its stake in shares of Ceridian HCM by 258.2% in the 3rd quarter. Allworth Financial LP now owns 978 shares of the company’s stock valued at $55,000 after buying an additional 705 shares in the last quarter. Finally, Wahed Invest LLC bought a new stake in shares of Ceridian HCM in the 2nd quarter valued at approximately $69,000.
About Ceridian HCM
Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.
Further Reading
- Get a free copy of the StockNews.com research report on Ceridian HCM (CDAY)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- Analysts Like The Fit Of Skechers USA
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.